Breast Cancer Research

official impact factor 5.79

Highly Access Review

Mammographic density and breast cancer risk: current understanding and future prospects

Norman F Boyd1,2*, Lisa J Martin1,2, Martin J Yaffe3 and Salomon Minkin2

Author Affiliations

1 Campbell Family Institute for Breast Cancer Research, Room 10-415, 610 University Avenue, Toronto, ON M5G 2M9, Canada

2 Ontario Cancer Institute, 610 University Avenue, Toronto, ON M5G 2M9, Canada

3 Imaging Research, 2075 Sunnybrook Health Sciences Centre, Bayview Avenue, Toronto, ON M4N 3M5, Canada

For all author emails, please log on.

Breast Cancer Research 2011, 13:223 doi:10.1186/bcr2942

Published: 1 November 2011

Abstract

Variations in percent mammographic density (PMD) reflect variations in the amounts of collagen and number of epithelial and non-epithelial cells in the breast. Extensive PMD is associated with a markedly increased risk of invasive breast cancer. The PMD phenotype is important in the context of breast cancer prevention because extensive PMD is common in the population, is strongly associated with risk of the disease, and, unlike most breast cancer risk factors, can be changed. Work now in progress makes it likely that measurement of PMD will be improved in the near future and that understanding of the genetics and biological basis of the association of PMD with breast cancer risk will also improve. Future prospects for the application of PMD include mammographic screening, risk prediction in individuals, breast cancer prevention research, and clinical decision making.